Feinstein Institutes unveils peptide therapy for sepsis and rheumatoid arthritis
Scientists at Northwell Health's Feinstein Institutes have developed a novel drug discovery strategy transforming a detrimental immune element into a therapeutic for sepsis and rheumatoid arthritis, published in Military Medical Research.